Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensations - Grants (Details)

v3.21.1
Stock-Based Compensations - Grants (Details)
$ / shares in Units, shares in Thousands, $ in Millions
3 Months Ended
Mar. 31, 2021
USD ($)
$ / shares
shares
Common Class A  
Number of options  
Outstanding at beginning of period | shares 40,553
Granted | shares 995
Exercised | shares (1,053)
Forfeited/Cancelled | shares (1,447)
Outstanding at end of period | shares 39,048
Exercisable at end of period | shares 22,876
WAEP  
Outstanding at beginning of period | $ / shares $ 10.61
Exercise price | $ / shares 12.90
Exercised | $ / shares 5.47
Forfeited/Cancelled | $ / shares 14.13
Outstanding at end of period | $ / shares 10.68
Exercisable at end of period | $ / shares $ 13.86
Additional disclosures  
Weighted average remaining life - options outstanding 4 years 1 month 6 days
Weighted average remaining life - options exercisable 2 years 10 months 24 days
Aggregate intrinsic value of options outstanding | $ $ 115
Aggregate intrinsic value of options exercisable | $ $ 19
Common Class B  
Number of options  
Outstanding at beginning of period | shares 3,243
Outstanding at end of period | shares 3,243
Exercisable at end of period | shares 3,243
WAEP  
Outstanding at beginning of period | $ / shares $ 15.39
Outstanding at end of period | $ / shares 15.39
Exercisable at end of period | $ / shares $ 15.39
Additional disclosures  
Weighted average remaining life - options outstanding 1 year 9 months 18 days
Weighted average remaining life - options exercisable 1 year 9 months 18 days